DE:3F80 Stock Latest News
Company AnnouncementsQ-linea grows ASTar footprint but U.S. adoption slows revenue targets3d ago
Company AnnouncementsQ-linea Appoints New CFO to Support Growth in Rapid Infection Diagnostics2M ago
Company AnnouncementsQ-linea secures Premier contract to accelerate U.S. rollout of ASTar system2M ago
Company AnnouncementsQ-linea Secures Key U.S. Health System Deal for ASTar Rapid Infection Diagnostics2M ago
Company AnnouncementsQ-linea Builds on FDA Clearance to Drive ASTar Expansion Amid Ongoing Losses3M ago
Company AnnouncementsQ-linea Names Annika Blondeau Henriksson Interim CFO and IR Chief5M agoCompany AnnouncementsQ-linea Builds Global Momentum on Expanded ASTar Panel and Leaner Cost Base6M ago
Company AnnouncementsQ-linea Calls 2026 AGM, Proposes No Dividend and New Incentive Plan6M ago
Company AnnouncementsQ-linea’s 2025 Report Highlights Rapid Infection Diagnostics and ASTar Platform6M ago- Company AnnouncementsQ-linea wins FDA clearance for expanded ASTar sepsis testing menu6M ago
- Company AnnouncementsQ-linea Expands Middle East Presence With ASTar Deployments in Saudi Arabia7M ago
Company AnnouncementsQ-linea Nomination Committee Proposes Stable Board and New Expertise Ahead of 2026 AGM7M ago
- Company AnnouncementsQ-linea Reshapes US Commercial Leadership to Drive ASTar® Adoption10M ago
- Company AnnouncementsQ-linea Enters South Asian Market With First Distribution Deal in Bangladesh10M ago
- Company AnnouncementsQ-linea’s ASTar Chosen to Replace Accelerate Pheno in Italian Laboratories10M ago
- Company AnnouncementsQ-linea Secures First U.S. Hospital Deployments of ASTar Rapid Testing System10M ago
Company AnnouncementsQ-linea AB Expands Share Capital to Strengthen Market Position11M ago